The global On-Body Delivery System (OBDS) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.
The on-body delivery system (OBDS) market is changing rapidly, and it has become clear that OBDS are critical to the delivery of some new drugs in development. The OBDS market is relatively young, which lends itself to exciting innovations and high potential growth rate. Many companies have products that are still in development and have not yet been commercialized.
ReportPrime, Inc. (LPI) ' newest research report, the “On-Body Delivery System (OBDS) Industry Forecast” looks at past sales and reviews total world On-Body Delivery System (OBDS) sales in 2024, providing a comprehensive analysis by region and market sector of projected On-Body Delivery System (OBDS) sales for 2025 through 2031. With On-Body Delivery System (OBDS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world On-Body Delivery System (OBDS) industry.
This Insight Report provides a comprehensive analysis of the global On-Body Delivery System (OBDS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on On-Body Delivery System (OBDS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global On-Body Delivery System (OBDS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for On-Body Delivery System (OBDS) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global On-Body Delivery System (OBDS).
This report presents a comprehensive overview, market shares, and growth opportunities of On-Body Delivery System (OBDS) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Push Drug Out Of Container
- Pull Drug Out Of Container
Segmentation by Application:
- Diabetes
- Parkinson'S Disease
- Cancer
- Cardiovascular Diseases
- Other
Market by Region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
Company's Coverage:
- West Pharmaceutical Services
- Gerresheimer
- Stevanato Group
- Enable Injections
- Insulet
- Ypsomed
- Bexson
- Nemera
- BD Medical
Key Questions Addressed in this Report:
- What is the 10-year outlook for the global On-Body Delivery System (OBDS) market?
- What factors are driving On-Body Delivery System (OBDS) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do On-Body Delivery System (OBDS) market opportunities vary by end market size?
- How does On-Body Delivery System (OBDS) break out by Type, by Application?
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market